Growth hormone deficiency after traumatic brain injury and effects of growth hormone replacement

Phase 4, open-label, single-arm trial of somatropin in growth hormone deficiency (GHD), sponsored by Radboud University Medical Center. Primary endpoints: Change in components of growth hormone deficiency syndrome before and after growth hormone substitution and Association of growth hormone deficiency with cardiovascular and functional impairment. Started Nov 2006; status: active.